Viatris Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Viatris Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both fell in each of the last 3 years. Less steady than 96% of Healthcare companies in United States.
- Cash Cushion Ratio: Debt, after subtracting cash, equals 62% of its market value (net debt). Lower than 93% of Healthcare companies in United States.
- Self-Funding Ratio: Over the last 3 years its own operating cash covered its investment spending (capex) 5.4 times. Higher than 88% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
5.4×Over the last 3 years its own operating cash covered its investment spending (capex) 5.4 times.
Higher than 88% of Healthcare companies in United States.
Cash Locked Ratio
$38For every $100 of sales, $38 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $34 tied up three years earlier.
More money tied up than 79% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
0/3 · 0/3Sales and profit both fell in each of the last 3 years.
Less steady than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 12%
Sales fell 12% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-12% / -26%In 3 years sales changed by -12% while total assets changed by -26%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
1.2×Debt due within a year is covered 1.2 times by its yearly operating cash.
Higher than 72% of Healthcare companies in United States.
Cash Cushion Ratio
−62%Debt, after subtracting cash, equals 62% of its market value (net debt).
Lower than 93% of Healthcare companies in United States.
Tangible Assets Ratio
41%Of every $100 the company owns, $41 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 87% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 87% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Viatris Inc. made a loss over the last year. Viatris Inc. owes $0.59 for every $1 it owns. Viatris Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossViatris Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
1.49The share price is 1.49 times Viatris Inc.'s book value per share, lower than 68% of Healthcare companies in United States.
Market cap
$21.2 BThe total market value of all of Viatris Inc.'s shares at today's price (share price × number of shares), larger than 94% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$14.3 BWhat Viatris Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$12.42Net worth divided by the number of shares. The share price of $18.48 is 1.5 times this, which is the P/B above.
Return on equity (ROE)
-2.8%Viatris Inc. lost 2.8% of its shareholders' money over the last year, higher than 74% of Healthcare companies in United States.
Owes vs Owns
0.59×Viatris Inc. owes $0.59 for every $1 it owns (moderate), higher than 64% of Healthcare companies in United States.
Dividend yield
2.60%Viatris Inc. pays 2.60% of its share price as dividends a year, higher than 87% of dividend-paying Healthcare companies in United States.
Revenue growth
-3%Revenue fell 3% in the year to Dec 2025, and shrank 4% a year on average over 3 years.
Profit growth
LossViatris Inc. made a loss in each of the last two years.
Profit margin
-24.6%Viatris Inc. lost $25 for every $100 of revenue.
Interest cover
0.5×Viatris Inc.'s operating profit covered its interest costs 0.5 times in the year to Dec 2025.
Cash vs debt
Net debtViatris Inc. had $13.2 B more debt than cash (net debt) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Viatris Inc.: $21.2 B ÷ $14.3 B (30 Jun 2026) = 1.5.
What is Viatris Inc.'s return on equity?
Viatris Inc. lost 2.8% of its shareholders' money over the last year, higher than 74% of Healthcare companies in United States.
How much does Viatris Inc. owe compared with what it owns?
Viatris Inc. owes $0.59 for every $1 it owns (moderate), higher than 64% of Healthcare companies in United States.
Does Viatris Inc. pay a dividend?
Yes. Viatris Inc. pays 2.60% of its share price as dividends a year, higher than 87% of dividend-paying Healthcare companies in United States.
Is Viatris Inc.'s revenue growing?
Revenue fell 3% in the year to Dec 2025, and shrank 4% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.